Harmony Biosciences Holdings (HRMY) Preferred Dividend Payments (2019 - 2020)
Harmony Biosciences Holdings (HRMY) reported Preferred Dividend Payments of $6.0 million for Q3 2020, down 33.39% on a YoY basis from $9.0 million in Q4 2019, and down 42.44% sequentially from $10.4 million in Q2 2020.
Harmony Biosciences Holdings (HRMY) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 2 years of Preferred Dividend Payments data on file, last reported at $6.0 million in Q3 2020.
- For the quarter ending Q3 2020, Preferred Dividend Payments fell 33.39% year-over-year to $6.0 million; the trailing twelve-month figure through Dec 2020 stood at $26.9 million (changed N/A YoY), and the FY2020 full-year result was $26.9 million, down 23.64% from the prior year.
- Preferred Dividend Payments eased to $6.0 million in Q3 2020, from $10.4 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $10.4 million in Q2 2020 to a low of $6.0 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 6.01 Mn |
| Jun 30, 2020 | 10.45 Mn |
| Mar 31, 2020 | 10.45 Mn |
| Dec 31, 2019 | 9.58 Mn |
| Sep 30, 2019 | 9.03 Mn |